Subscribe to RSS

DOI: 10.1055/a-2665-2209
Very Rare Case of Hyaline Fibromatosis Syndrome Successfully Treated with Surgical Excision and Review of Literature
Authors
Abstract
Hyaline fibromatosis syndrome (HFS) is a rare autosomal recessive disorder caused by ANTXR2 gene mutations, resulting in abnormal deposition of hyaline material in connective tissues. Fewer than 100 cases have been documented worldwide. Patients often present with painful joint contractures, gingival hyperplasia, cutaneous nodules, and restricted mobility. Here, we report a 7-year-old boy with HFS who underwent surgical management for near-total obstruction of the external ear canal and multiple ulcerative lesions. A multidisciplinary approach facilitated successful mass excision and reconstruction with a split-thickness skin graft. Postoperative evaluations showed stable wound healing at 6 months, allowing consideration of further surgeries. This case highlights the importance of comprehensive genetic assessment, careful preoperative planning, and individualized surgical intervention, as well as the critical role of nutritional support to optimize wound healing and clinical outcomes in HFS.
Introduction
Hyaline fibromatosis syndrome (HFS) represents an autosomal recessive condition marked by excessive deposition of hyaline material in connective tissues across multiple body systems. This rare disorder, caused by mutations in the ANTXR2 gene, presents in two forms: The severe infantile systemic hyalinosis (ISH) and the milder juvenile hyaline fibromatosis (JHF).[1] With only around 100 documented cases worldwide,[2] HFS is characterized by significant morbidity, and its management requires a comprehensive understanding of the underlying pathology and potential complications. The unification of ISH and JHF into a single entity, proposed in 2009 by Nofal et al.,[3] highlights the similar genetic underpinnings of these forms, though they differ in presentation and severity.
Historically, HFS was first identified by Murray in 1873 under the term “molluscum fibrosum,”[4] and it has since posed considerable challenges in clinical management. There is a dearth of literature on effective surgical management and postoperative outcomes, particularly concerning wound healing and the impacts of tissue structure on graft uptake. This case report contributes to the existing literature by detailing the surgical and postoperative course of HFS in a pediatric patient.
Case
The patient and parents provided written informed consent for the use of the patient's medical records and photographs in this case report.
A 7-year-old male with genetically confirmed HFS was referred to plastic surgery for management of ulcerative skin lesions and an obstructive posterior ear mass. The mass caused partial blockage of the external auditory meatus, potentially leading to complications in hearing and further treatment. Additional ulcerative lesions were noted on the sacrum and neck, likely due to pressure-related issues from limited mobility ([Fig. 1]). This case represents a relatively typical clinical manifestation of HFS.


Preoperative considerations focused on airway management and patient positioning due to the complex anatomical features associated with HFS. Joint contractures, temporomandibular stiffness, and hyaline deposition in the oral and nasal cavities posed significant challenges for intubation. A pediatric otolaryngologist conducted a detailed airway assessment, and a computed tomography scan was obtained to evaluate airway patency and identify potential obstructions. Given the limited mouth opening and gingival hyperplasia, nasotracheal intubation under fiberoptic guidance was selected, with emergency tracheostomy prepared as a contingency.
Patient positioning required meticulous planning. Cervical spine contractures necessitated specialized support to ensure stability and comfort during the procedure. The left lateral decubitus position provided optimal surgical access to the affected ear while minimizing strain on contracted joints. Additional padding was applied to prevent pressure-related complications, particularly over previously affected areas such as the sacrum.
Surgical intervention included excision of the auricular mass followed by reconstruction using a split-thickness skin graft harvested from the left lateral thigh. A tie-over dressing was applied to enhance graft adherence. Histopathological analysis confirmed a diagnosis of JHF ([Fig. 2]). The patient exhibited satisfactory wound healing over 6 months ([Fig. 3]), permitting subsequent staged procedures. These included excision and reconstruction of lesions on the heel and sacral regions utilizing local flaps, with a primary focus on tension-free closure to facilitate optimal healing.




Following initial procedures, additional surgeries were performed to excise fibrous masses on the buttock, neck, and heel. At 20 months postoperatively, a recurrent mass with overlying inflammation appeared on the right auricle, necessitating another excision and skin grafting, which was completed without complications. Recurrence was noted within 2 months following the initial surgery. Although gross total excision was achieved during the first operation, a microscopic residual lesion is presumed to have led to recurrence. During the second procedure, dissection from the perichondrium was performed without difficulty, and no significant adhesions or unusual intraoperative findings were observed. Intraoperative bleeding was minimal and within the expected range for this type of surgery.
At the age of 2, a gastrostomy tube was placed due to feeding difficulties; however, site bleeding prompted further evaluation with esophagogastroduodenoscopy and consultation with a nutrition specialist. The patient continues to require multidisciplinary management, including physiotherapy from the Department of Rehabilitation Medicine, orthopedic follow-up for knee contractures, and otolaryngologic surveillance of airway patency.
Discussion
While some authors differentiate ISH from JHF, both present overlapping clinical features like skin lesions, subcutaneous masses, gingival hyperplasia, joint stiffness, and osteopenia.[5] ISH, however, often involves higher mortality due to complications like severe diarrhea and recurrent bacteremia.[6] Despite clinical differences, both syndromes share the same ANTXR2 gene mutation, supporting the unified term “HFS.”[1] Based on symptom presentation, our patient's HFS aligns with grade 2 (moderate severity).[3]
Neurofibromatosis, gingival hyperplasia, nodular amyloidosis, Winchester syndrome, and lipoid proteinosis, along with inborn metabolic disorders such as Farber's disease, mucopolysaccharidoses, and I-cell disease, could be considered in the differential diagnosis of HFS.[7] Although these conditions share clinical features with HFS, the underlying genetic mutations responsible for each condition are distinct. Therefore, a genetic analysis is crucial for accurate differential diagnosis and appropriate management.
Standard treatments for joint contractures, such as intralesional or systemic steroid therapy and oral D-penicillamine,[8] often yield limited results. Steroid therapy may cause symptom recurrence, and in our case, inflammatory wound conditions contraindicate its use. A review of several articles on HFS treatment, including surgical approaches ([Table 1]),[8] [9] [10] [11] [12] [13] [14] [15] led us to conclude that, despite concerns about surgical intervention potentially stimulating further hyaline deposition, excision of painful or infected lesions can provide substantial symptomatic relief. This finding is supported by previous studies[9] [11] [13] and was observed in our patient as well. Surgical excision should be viewed as palliative, not curative, due to frequent recurrence.[10] Unlike keloid formation, where recurrence often occurs shortly after surgery, HFS typically exhibits a remission period postexcision, allowing surgeons to perform excisions with the goal of palliation.
|
Study |
Year |
Ethnicity |
Number of patients/sample size |
Treatment modality |
Location of lesion |
Follow-up period |
Outcomes |
Comments |
|---|---|---|---|---|---|---|---|---|
|
Woyke et al.[9] |
1984 |
Not specified |
2 cases |
Surgical excision |
Scalp, shoulders, back, and extremities. gingivae, face, hand, and fingers. |
19 years |
Successful removal of nearly all masses; recurrence frequently reported |
– |
|
El-Maaytah et al.[8] |
2010 |
Middle Eastern |
1 case |
Surgical excision+ Oral D-penicillamine+ Physiotherapy |
Scalp, gingivae, face, and left arm |
15 years |
Successful removal of masses, though recurrence frequently reported. Joint contracture improved. |
Duration of D-penicillamine treatment was not specified. |
|
Krishnamurthy et al.[10] |
2011 |
Not specified |
1 case |
Surgical excision |
Scalp, back, face, chest, and abdomen |
7 years |
Successful removal of masses; recurrence frequently reported |
– |
|
Marques et al.[11] |
2016 |
Not specified |
1 case |
Surgical excision |
Shoulder, back, face, arm, and finger |
20 years |
Successful removal of nearly all masses; recurrence frequently reported |
Only 1 patient out of 2 had treatment and follow-up history. |
|
Baltacioglu et al.[12] |
2017 |
Not specified |
1 case |
Surgical excision+ Systemic steroid |
Gingivae, face, and perianal region |
10 years |
Successful removal of nearly all masses; recurrence frequently reported |
Steroid effect not mentioned |
|
Braizat et al.[13] |
2020 |
African |
1 case |
Surgical excision+ Systemic and Intralesional steroid+ Physiotherapy |
Gingivae, face, hand, back, and big toe |
5 years |
Successful removal of nearly all masses. Recurrence reported. Systemic and intralesional steroids were effective, but physiotherapy was not |
Recurrence was confined to hand lesions. |
|
Song et al.[14] |
2021 |
Not specified |
5 cases |
Surgical excision |
Scalp, face, hand, knee, back, shoulder, elbow, arm, thigh, and foot |
1–10 years |
Successful removal of nearly all masses. Recurrence reported |
One patient in the case series lacked recurrence details. |
|
Chaisrisawadisuk et al.[15] |
2024 |
Not specified |
1 case |
Surgical excision |
Scalp, gingivae |
4 month |
Successful removal of mass; no recurrence |
– |
Given the compromised skin condition, primary closure was not viable; split-thickness skin grafting was used. While no specific studies address graft uptake in HFS, our patient's graft integrated successfully, indicating hyaline deposition may not hinder short-term outcomes. Physiotherapy did not benefit our patient, as joint splints caused discomfort and no noticeable improvements were observed, consistent with previous reports on HFS. In contrast, nutritional support played a critical role in the patient's recovery,[16] particularly given the gastrointestinal complications common in HFS, such as villous atrophy, intestinal edema, and lymphangiectasia, which can lead to chronic diarrhea.[3] These conditions increase the risk of malnutrition, potentially hindering wound healing and recovery. Proper nutrition facilitated wound healing, particularly after surgical interventions, and proved essential for maintaining overall stability in the patient's health.
Airway management was particularly challenging due to temporomandibular and cervical joint contractures, along with hyaline deposits in the oral, nasal, and tracheal areas.[17] [18] [19] Thorough preoperative assessment by pediatric otolaryngology and anesthesiology, including CT imaging for airway patency, was essential.[17] [18] Although guidelines recommend conscious intubation for difficult airways,[20] this approach is often impractical in young children. Limited mouth opening and gingival hyperplasia precluded standard airway device use, making nasal fiberoptic intubation the preferred option. Despite visualization challenges from hypertrophied soft tissues, nasotracheal intubation was successful. An emergency tracheostomy setup was prepared, and extubation was performed with caution, ready for emergent reintubation if needed.
Our case report presents several limitations. It lacks a pathological analysis of the postoperative wounds related to the skin graft, which complicates the assessment of whether the graft uptake process corresponds with the typical postoperative course observed in skin grafts. Additionally, we opted not to utilize local or systemic steroid therapy due to the patient's wound condition, leaving the potential effects of steroid therapy on the healing process unexplored within the context of this case. Lastly, as this is a case report, it underscores the necessity of accumulating clinical experience to foster a more comprehensive understanding of HFS.
Conclusion
Managing HFS involves addressing both the unique pathophysiological challenges and the complex postoperative needs associated with this syndrome. Genetic testing is imperative for accurate diagnosis, and multidisciplinary care is essential for optimizing outcomes. This case report highlights the efficacy of split-thickness skin grafting and tension-free reconstruction in HFS patients and reinforces the importance of comprehensive nutritional support and preoperative planning. Surgical intervention can provide symptomatic relief, but recurrence is common, necessitating clear patient communication regarding long-term management.
Conflict of Interest
None declared.
Authors' Contributions
Y.U.J.: Conceptualization, data curation, formal analysis, investigation, methodology, resources, visualization, writing—original draft.
B-j.K.: Conceptualization, project administration, supervision, validation, writing—review and editing.
E-H.K.: Data curation, investigation, supervision, validation, writing—original draft, writing—review and editing.
Ethical Approval
IRB approval was not required.
Patient Consent
The patient and parents provided written informed consent for the use of the patient's medical records and photographs in this case report.
-
References
- 1 Mantri MD, Pradeep MM, Kalpesh PO, Pranavsinh RJ. Hyaline fibromatosis syndrome: A rare inherited disorder. Indian J Dermatol 2016; 61 (05) 580
- 2 Xia L, Hu Y, Zhang C, Wu D, Chen Y. Juvenile hyaline fibromatosis: a rare oral disease case report and literature review. Transl Pediatr 2021; 10 (11) 3124-3129
- 3 Nofal A, Sanad M, Assaf M. et al. Juvenile hyaline fibromatosis and infantile systemic hyalinosis: a unifying term and a proposed grading system. J Am Acad Dermatol 2009; 61 (04) 695-700
- 4 Murray J. On three peculiar cases of molluscum fibrosum in children in which one or more of the following conditions were observed: Hypertrophy of the gums, enlargement of the ends of the fingers and toes, numerous connective-tissue tumours on the scalp, &c. Med Chir Trans 1873; 56: 235-254.1
- 5 Thomas JE, Moossavi M, Mehregan DR, McFalda WL, Mahon MJ. Juvenile hyaline fibromatosis: A case report and review of the literature. Int J Dermatol 2004; 43 (11) 785-789
- 6 Stucki U, Spycher MA, Eich G. et al. Infantile systemic hyalinosis in siblings: Clinical report, biochemical and ultrastructural findings, and review of the literature. Am J Med Genet 2001; 100 (02) 122-129
- 7 Dhingra M, Amladi S, Savant S, Nayak C. Juvenile hyaline fibromatosis and infantile systemic hyalinosis: Divergent expressions of the same genetic defect?. Indian J Dermatol Venereol Leprol 2008; 74 (04) 371-374
- 8 El-Maaytah M, Jerjes W, Shah P, Upile T, Murphy C, Ayliffe P. Gingival hyperplasia associated with juvenile hyaline fibromatosis: A case report and review of the literature. J Oral Maxillofac Surg 2010; 68 (10) 2604-2608
- 9 Woyke S, Domagala W, Markiewicz C. A 19-year follow-up of multiple juvenile hyaline fibromatosis. J Pediatr Surg 1984; 19 (03) 302-304
- 10 Krishnamurthy J, Dalal BS, Sunila, Gubanna MV. Juvenile hyaline fibromatosis. Indian J Dermatol 2011; 56 (06) 731-733
- 11 Marques SA, Stolf HO, Polizel JO, Munhoz T, Brandao MC, Marques ME. Hyaline fibromatosis syndrome: cutaneous manifestations. An Bras Dermatol 2016; 91 (02) 226-229
- 12 Baltacioglu E, Guzeldemir E, Sukuroglu E. et al. Juvenile hyaline fibromatosis: A 10-year follow-up. Indian J Dermatol 2017; 62 (02) 210-212
- 13 Braizat O, Badran S, Hammouda A. Juvenile hyaline fibromatosis: Literature review and a case treated with surgical excision and corticosteroid. Cureus 2020; 12 (10) e10823
- 14 Song L, Yang J, Liu J, Wang J. Juvenile hyaline fibromatosis: A clinicopathological study of five cases. Ann Diagn Pathol 2021; 55: 151835
- 15 Chaisrisawadisuk S, Rattana-Arpa S, Vathanophas V, Sathienkijkanchai A. Hyaline fibromatosis syndrome: early outcomes following major craniofacial mass excision. J Craniofac Surg 2024; 35 (05) e492-e495
- 16 Grada A, Phillips TJ. Nutrition and cutaneous wound healing. Clin Dermatol 2022; 40 (02) 103-113
- 17 Norman B, Soni N, Madden N. Anaesthesia and juvenile hyaline fibromatosis. Br J Anaesth 1996; 76 (01) 163-166
- 18 Yasuda A, Miyazawa N, Inoue E, Imai T, Shionoya Y, Nakamura K. Anesthetic management of a juvenile hyaline fibromatosis patient with trismus and cervical movement limitation. Anesth Prog 2021; 68 (02) 117-118
- 19 Segal S, Khanna AK. Anesthetic management of a patient with juvenile hyaline fibromatosis: A case report written with the assistance of the large language model ChatGPT. Cureus 2023; 15 (03) e35946
- 20 Apfelbaum JL, Hagberg CA, Connis RT. et al. 2022 American Society of Anesthesiologists Practice Guidelines for Management of the Difficult Airway. Anesthesiology 2022; 136 (01) 31-81
Address for correspondence
Publication History
Received: 11 March 2025
Accepted: 14 July 2025
Accepted Manuscript online:
25 July 2025
Article published online:
20 November 2025
© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)
Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
-
References
- 1 Mantri MD, Pradeep MM, Kalpesh PO, Pranavsinh RJ. Hyaline fibromatosis syndrome: A rare inherited disorder. Indian J Dermatol 2016; 61 (05) 580
- 2 Xia L, Hu Y, Zhang C, Wu D, Chen Y. Juvenile hyaline fibromatosis: a rare oral disease case report and literature review. Transl Pediatr 2021; 10 (11) 3124-3129
- 3 Nofal A, Sanad M, Assaf M. et al. Juvenile hyaline fibromatosis and infantile systemic hyalinosis: a unifying term and a proposed grading system. J Am Acad Dermatol 2009; 61 (04) 695-700
- 4 Murray J. On three peculiar cases of molluscum fibrosum in children in which one or more of the following conditions were observed: Hypertrophy of the gums, enlargement of the ends of the fingers and toes, numerous connective-tissue tumours on the scalp, &c. Med Chir Trans 1873; 56: 235-254.1
- 5 Thomas JE, Moossavi M, Mehregan DR, McFalda WL, Mahon MJ. Juvenile hyaline fibromatosis: A case report and review of the literature. Int J Dermatol 2004; 43 (11) 785-789
- 6 Stucki U, Spycher MA, Eich G. et al. Infantile systemic hyalinosis in siblings: Clinical report, biochemical and ultrastructural findings, and review of the literature. Am J Med Genet 2001; 100 (02) 122-129
- 7 Dhingra M, Amladi S, Savant S, Nayak C. Juvenile hyaline fibromatosis and infantile systemic hyalinosis: Divergent expressions of the same genetic defect?. Indian J Dermatol Venereol Leprol 2008; 74 (04) 371-374
- 8 El-Maaytah M, Jerjes W, Shah P, Upile T, Murphy C, Ayliffe P. Gingival hyperplasia associated with juvenile hyaline fibromatosis: A case report and review of the literature. J Oral Maxillofac Surg 2010; 68 (10) 2604-2608
- 9 Woyke S, Domagala W, Markiewicz C. A 19-year follow-up of multiple juvenile hyaline fibromatosis. J Pediatr Surg 1984; 19 (03) 302-304
- 10 Krishnamurthy J, Dalal BS, Sunila, Gubanna MV. Juvenile hyaline fibromatosis. Indian J Dermatol 2011; 56 (06) 731-733
- 11 Marques SA, Stolf HO, Polizel JO, Munhoz T, Brandao MC, Marques ME. Hyaline fibromatosis syndrome: cutaneous manifestations. An Bras Dermatol 2016; 91 (02) 226-229
- 12 Baltacioglu E, Guzeldemir E, Sukuroglu E. et al. Juvenile hyaline fibromatosis: A 10-year follow-up. Indian J Dermatol 2017; 62 (02) 210-212
- 13 Braizat O, Badran S, Hammouda A. Juvenile hyaline fibromatosis: Literature review and a case treated with surgical excision and corticosteroid. Cureus 2020; 12 (10) e10823
- 14 Song L, Yang J, Liu J, Wang J. Juvenile hyaline fibromatosis: A clinicopathological study of five cases. Ann Diagn Pathol 2021; 55: 151835
- 15 Chaisrisawadisuk S, Rattana-Arpa S, Vathanophas V, Sathienkijkanchai A. Hyaline fibromatosis syndrome: early outcomes following major craniofacial mass excision. J Craniofac Surg 2024; 35 (05) e492-e495
- 16 Grada A, Phillips TJ. Nutrition and cutaneous wound healing. Clin Dermatol 2022; 40 (02) 103-113
- 17 Norman B, Soni N, Madden N. Anaesthesia and juvenile hyaline fibromatosis. Br J Anaesth 1996; 76 (01) 163-166
- 18 Yasuda A, Miyazawa N, Inoue E, Imai T, Shionoya Y, Nakamura K. Anesthetic management of a juvenile hyaline fibromatosis patient with trismus and cervical movement limitation. Anesth Prog 2021; 68 (02) 117-118
- 19 Segal S, Khanna AK. Anesthetic management of a patient with juvenile hyaline fibromatosis: A case report written with the assistance of the large language model ChatGPT. Cureus 2023; 15 (03) e35946
- 20 Apfelbaum JL, Hagberg CA, Connis RT. et al. 2022 American Society of Anesthesiologists Practice Guidelines for Management of the Difficult Airway. Anesthesiology 2022; 136 (01) 31-81





